Table of Content

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What’s New in This Update?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Chapter 2 Summary and Highlights
Chapter 3 Market Dynamics
Drivers
Wide Range of Potential Applications of Combinations Products
Increasing Number of Diseases
Recent Approvals and Launch of Novel Drug-device Combination Products
Restraints
Limitations Associated with Drug-Device Combination Products
Regulatory Challenges
Opportunities
Key Players Focusing on Inorganic Strategies in the Drug-Device Combination Products Market
Chapter 4 Market Overview
Market Insights
Regulatory Landscape
Patent Review
Product Recalls
Product Pipeline
Market Trends
Future Perspective
Strategies and Developments
Chapter 5 Impact of COVID-19
Overview
COVID-19 Crisis
Impact on Market for Drug-Device Combination Products
Current Outlook
Chapter 6 Market Breakdown by Product Type
Drug/Biologic-Device Combination Products
Drug Eluting Stents (DES)
Prefilled Syringe (PFS)
Inhalers
Nebulizer
Wound Care Products
Implants
Antimicrobial Catheters
Photodynamic Therapy (PDT)
Transdermal Patches
Others
Drug-Biologic Drug-Device Combination Products
Antibody-Drug Conjugates (ADC)
Monoclonal Antibodies (mAbs)
Others
Drug and Device and Biologic Combination Products
Chapter 7 Market Breakdown by Application
Cardiovascular Diseases
Metabolic Disorders
Respiratory Diseases
Wound Care
Orthopedic Conditions
Oncology
Others
Chapter 8 Market Breakdown by Region
Overview
North America
Europe
Asia-Pacific
Rest of the World
Chapter 9 Competitive Landscape
Company Share Analysis
Chapter 10 Company Profiles
Company Profiles
3M
ABBOTT
B. BRAUN MELSUNGEN AG
BD
BOSTON SCIENTIFIC CORP.
COSMED PHARMACEUTICAL CO., LTD.
JOHNSON & JOHNSON SERVICES INC.
MEDTRONIC INC.
SANOFI S.A.
SMITH & NEPHEW PLC
STRYKER CORP.
TERUMO CORP.
Chapter 11 Appendix: List of Acronyms



List of Figures


Summary Figure : Global Market Shares of Drug-Device Combination Products, by Product Type, 2020
Figure 1 : U.S. FDA Combination Product Approval Pathway
Figure 2 : Global Market for Drug-Device Combination Products, 2019-2026
Figure 3 : Global Market for Drug/Biologic-Device Combination Products, 2019-2026
Figure 4 : Global Market for Drug-Biologic Combination Products, 2019-2026
Figure 5 : Global Market for Drug and Device and Biologic Combination Products, 2019-2026
Figure 6 : Global Market for Drug-Device Combination Products, by Application, 2019-2026
Figure 7 : Global Market for Drug-Device Combination Products for Cardiovascular Diseases, 2019-2026
Figure 8 : Global Market for Drug-Device Combination Products for Metabolic Disorders, 2019-2026
Figure 9 : Global Market for Drug-Device Combination Products for Respiratory Diseases, 2019-2026
Figure 10 : Global Market for Drug-Device Combination Products for Wound Care, 2019-2026
Figure 11 : Global Market for Drug-Device Combination Products for Orthopedic Conditions, 2019-2026
Figure 12 : Global Market for Drug-Device Combination Products for Oncology, 2019-2026
Figure 13 : Global Market for Drug-Device Combination Products for Other Chronic Diseases, 2019-2026
Figure 14 : Global Market Shares of Drug-Device Combination Products, by Region, 2020
Figure 15 : North American Market for Drug-Devices Combination Product, by Country, 2019-2026
Figure 16 : North American Market for Drug-Devices Combination Product, by Country, 2019-2026
Figure 17 : European Market for Drug-Device Combination Products, by Country, 2019-2026
Figure 18 : European Market Shares of Drug-Device Combination Products, by Country, 2020
Figure 19 : Asia-Pacific Market for Drug-Device Combination Products, by Country, 2019-2026
Figure 20 : Asia-Pacific Market Shares of Drug-Device Combination Products, by Country, 2020
Figure 21 : Global Market Shares of Drug-Device Combination Products, by Company, 2020
Figure 22 : 3M: Annual Revenue, 2018-2020
Figure 23 : 3M: Revenue Share, by Business Segment, 2020
Figure 24 : 3M: Revenue Share, by Business Segment, 2020
Figure 25 : Abbott: Annual Revenue, 2018-2020
Figure 26 : Abbott: Revenue Share, by Business Segment, 2020
Figure 27 : Abbott: Medical Devices Revenue--Vascular (Coronary Endovascular), 2019 and 2020
Figure 28 : B. Braun Melsungen AG: Annual Revenue, 2018-2020
Figure 29 : B. Braun Melsungen AG: Revenue Share, by Division, 2020
Figure 30 : BD: Annual Revenue, 2018-2020
Figure 31 : BD: Revenue Share, by Business Segment, 2020
Figure 32 : BD: Medical Segment Revenue--Medication Delivery Solutions, 2019 and 2020
Figure 33 : BD: Combination Product
Figure 34 : BD: Key Development
Figure 35 : Boston Scientific Corp.: Cardiovascular Revenue (Interventional Cardiology), 2019 and 2020
Figure 36 : Johnson & Johnson Services Inc.: Annual Revenue, 2018-2020
Figure 37 : Johnson & Johnson Services Inc.: Revenue Share, by Business Segment, 2020
Figure 38 : Johnson & Johnson Services Inc.: Medical Devices Revenue Orthopedics, 2019 and 2020
Figure 39 : Medtronic: Annual Revenue, 2018-2020
Figure 40 : Medtronic: Revenue Share, by Business Segment, 2020
Figure 41 : Sanofi S.A.: Annual Revenue, 2018-2020
Figure 42 : Sanofi S.A.: Revenue Share, by Business Unit, 2020
Figure 43 : Smith & Nephew: Annual Revenue, 2018-2020
Figure 44 : Smith & Nephew: Revenue Share, by Business Segment, 2020
Figure 45 : Smith & Nephew: Advanced Wound Management Segment Revenue, Advanced Wound Care (AWC), 2019-2020
Figure 46 : Stryker Corp.: Annual Revenue, 2018-2020
Figure 47 : Stryker Corp.: Revenue Share, by Business Segment, 2020
Figure 48 : Terumo Corp.: Annual Revenue, 2018-2020
Figure 49 : Terumo Corp.: Revenue Share, by Business Segment, 2020
Figure 50 : Terumo Corp.: Cardiac and Vascular Company Revenue Interventional Systems (TIS), 2019 and 2020

List of Tables


Summary Table : Global Market for Drug-Device Combination Products, by Product Type, Through 2026
Table 1 : EU Combination Product Regulation
Table 2 : Patents on Drug-Device Combination Products, 2011-2021
Table 3 : Recalled Drug-Device Combination Products
Table 4 : Drug-Device Combination Product Pipeline
Table 5 : Recent Strategies and Developments, 2018-2021
Table 6 : Global Market for Drug-Device Combination Products, by Product Type, Through 2026
Table 7 : Global Market for Drug/Biologic-Device Combination Products, by Product Type, Through 2026
Table 8 : Global Market for Drug/Biologic-Device Combination Products, by Region, Through 2026
Table 9 : Global Market for Drug-Biologic Combination Products, by Product Type, Through 2026
Table 10 : Global Market for Drug-Biologic Combination Products, by Region, Through 2026
Table 11 : Global Market for Drug and Device and Biologic Combination Products, by Region, Through 2026
Table 12 : Global Market for Drug-Device Combination Products, by Application, Through 2026
Table 13 : Global Market for Drug-Device Combination Products for Cardiovascular Diseases, by Region, Through 2026
Table 14 : Global Market for Drug-Device Combination Products for Metabolic Disorders, by Region, Through 2026
Table 15 : Global Market for Drug-Device Combination Products for Respiratory Diseases, by Region, Through 2026
Table 16 : Global Market for Drug-Device Combination Products for Wound Care, by Region, Through 2026
Table 17 : Global Market for Drug-Device Combination Products for Orthopedic Conditions, by Region, Through 2026
Table 18 : Global Market for Drug-Device Combination Products in Oncology, by Region, Through 2026
Table 19 : Global Market for Drug-Device Combination Products for Other Chronic Diseases, by Region, Through 2026
Table 20 : Global Market for Drug-Device Combination Products, by Region, Through 2026
Table 21 : U.S. Estimates for Influenza Disease Burden, by Age Group, 2019-2020
Table 22 : North American Market for Drug-Device Combination Products, by Country, Through 2026
Table 23 : European Market for Drug-Device Combination Products, by Country, Through 2026
Table 24 : Asia-Pacific Market for Drug-Device Combination Products, by Country, Through 2026
Table 25 : Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
Table 26 : Market Players and the Products They Offer for Various Applications
Table 27 : Terumo Corp.: R&D Investment, 2018-2020
Table 28 : 3M: Drug-Device Combination Products
Table 29 : 3M: Key Developments
Table 30 : Abbott: Drug-Device Combination Products
Table 31 : Abbott: Key Developments
Table 32 : B. Braun Melsungen AG: Drug-device combination products
Table 33 : BD: Combination Product
Table 34 : BD: Key Development
Table 35 : Boston Scientific Corp.: drug-Device Combination Products
Table 36 : CosMED Pharmaceutical Co., Ltd.: Combination Product
Table 37 : Johnson & Johnson Services Inc.: Combination Product
Table 38 : Medtronic: Drug-device combination products
Table 39 : Medtronic: Key Developments
Table 40 : Sanofi S.A.: Combination Product
Table 41 : Sanofi S.A.: Key Development
Table 42 : Smith & Nephew: Combination Product
Table 43 : Stryker Corp.: Drug-Device Combination Products
Table 44 : Terumo Corp.: Combination Product
Table 45 : Terumo Corp.: Key Developments
Table 46 : Acronyms Used in This Report